This inventor holds 1 USPTO granted patent. Top assignees: Korea Advanced Institute of Science and Technology, Labgenomics Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016
Title: Cheulhee Jung: Innovator in Genitourinary Infection Diagnosis
Introduction
Cheulhee Jung is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the area of genitourinary infections. His innovative work has the potential to enhance the accuracy and efficiency of infection diagnosis in healthcare settings.
Latest Patents
Cheulhee Jung holds a patent for a DNA chip designed for the diagnosis of genitourinary infections. This DNA chip is equipped with oligonucleotide probes that can detect fourteen different pathogens associated with genitourinary infections. The technology allows for rapid and precise analysis of infections, including the ability to identify multiple infections from various samples. The DNA chip is noted for its high sensitivity, specificity, and reproducibility, making it a valuable tool for primary health care institutions.
Career Highlights
Throughout his career, Cheulhee Jung has worked with notable organizations, including Labgenomics Co., Ltd. and the Korea Advanced Institute of Science and Technology. His experience in these institutions has contributed to his expertise in medical diagnostics and innovation.
Collaborations
Cheulhee Jung has collaborated with esteemed colleagues such as Hyun Gyu Park and Ki Soo Park. Their joint efforts have further advanced the research and development of diagnostic technologies.
Conclusion
Cheulhee Jung's contributions to the field of genitourinary infection diagnosis exemplify the impact of innovative thinking in healthcare. His patented DNA chip represents a significant advancement in medical diagnostics, promising improved patient outcomes through accurate and efficient testing methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile